US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NeOnc Technologies Holdings

3.41

+0.10503.18%

Pre-market: 3.420.0188+0.55%04:12 EDT

Volume:131.72K

Turnover:442.05K

Market Cap:98.08M

PE:-1.59

High:3.47

Open:3.28

Low:3.19

Close:3.30

52wk High:12.99

52wk Low:2.96

Shares:28.81M

Float Shares:14.72M

Volume Ratio:0.91

T/O Rate:0.90%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1361

EPS(LYR):-3.2036

ROE:--

ROA:-634.99%

PB:-4.53

PE(LYR):-1.06

Loading ...

Overview Company News Filings

Neonc Technologies - to Request Type B FDA Meeting for Neo100 Registrational Pathway

THOMSON REUTERS

NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data

NeOnc Technologies Issues Warrants for 3,571,430 Shares in USD 15 Million Registered Direct Offering

Neonc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules with New and Existing Institutional Investors

THOMSON REUTERS

Neonc Technologies - to Sell 3,571,430 Shares and Warrants at $4.20 Per Share

THOMSON REUTERS

Press Release: NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules with New and Existing Institutional Investors

NeOnc' Phase 2 Data Could Put Cancer on the Ropes

NeOnc Technologies Price Target Maintained with a $15.00/Share by BTIG

NeOnc’s Phase 2A Success Could Set the Stage for Something Much Bigger

NeOnc’s Clinical Story Is Now the Main Event

NeOnc Technologies Amends 8-K to Name Nasim Shomali to Audit Committee

Calendar of U.S. Earnings Expected in the Week Ahead

Neonc Technologies CEO Thomas C. Chen Acquires $70,010 of Common Shares Via IRA

NeOnc Technologies Hosts Annual Shareholder Meeting Via Webcast

Calendar of U.S. Earnings Expected in the Week Ahead

NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t

Neonc Technologies CEO Amir F Heshmatpour Acquires USD 58,521 of Common Shares

NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results

NeOnc Technologies Releases Transcript of Investor Call on Neo100-01 Phase 2a Trial Results in Recurrent IDH1-Mutant High-Grade Glioma

The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/NTHI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTHI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","market":"US","secType":"STK","nameCN":"NeOnc Technologies Holdings","latestPrice":3.405,"timestamp":1790798400000,"preClose":3.3,"halted":0,"volume":131723,"hourTrading":{"tag":"盘前","latestPrice":3.4238,"preClose":3.405,"latestTime":"04:12 EDT","volume":10,"amount":34.238,"timestamp":1790842357249,"change":0.0188,"changeRate":0.005521,"amplitude":0},"delay":0,"changeRate":0.031818181818181815,"floatShares":14715982,"shares":28805400,"eps":-2.136127,"marketStatus":"Pre-Mkt","change":0.105,"latestTime":"10-01 04:59:28 EDT","open":3.28,"high":3.47,"low":3.19,"amount":442049.5713521,"amplitude":0.084848,"askPrice":4.01,"askSize":100,"bidPrice":3.11,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.136127,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"listingDate":1711512000000,"exchange":"NASDAQ","adjPreClose":3.405,"preHourTrading":{"tag":"盘前","latestPrice":3.4238,"preClose":3.405,"latestTime":"04:12 EDT","volume":10,"amount":34.238,"timestamp":1790842357249,"change":0.0188,"changeRate":0.005521,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.45,"preClose":3.405,"latestTime":"19:30 EDT","volume":5723,"amount":19584.2306,"timestamp":1790811003304,"change":0.045,"changeRate":0.013216,"amplitude":0.079295},"volumeRatio":0.9098123776043539},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTHI\",,,,,undefined,":{"symbol":"NTHI","floatShares":14715982,"roa":"-634.99%","roe":"--","lyrEps":-3.203615,"volumeRatio":0.9098123776043539,"shares":28805400,"dividePrice":0,"high":3.47,"amplitude":0.084848,"preClose":3.3,"low":3.19,"week52Low":2.955,"pbRate":"-4.53","psRate":"2452.67","week52High":12.99,"institutionHeld":0,"latestPrice":3.405,"eps":-2.136127,"divideRate":0,"volume":131723,"delay":0,"ttmEps":-2.136127,"open":3.28,"prevYearClose":8.27,"prevWeekClose":3.31,"prevMonthClose":3.405,"prevQuarterClose":3.405,"fiveDayClose":3.22,"twentyDayClose":4.73,"sixtyDayClose":4.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTHI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"NTHI","fiscalQuarterEnding":"2026/06","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2026-05-15","symbol":"NTHI","fiscalQuarterEnding":"2026/03","expectedEps":-0.3,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2026-03-31","symbol":"NTHI","fiscalQuarterEnding":"2025/12","expectedEps":-0.37,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":-0.72},{"market":"US","date":"2025-11-14","symbol":"NTHI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-18","symbol":"NTHI","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1755489600000,"reportTimeType":"","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTHI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTHI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1790308800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NTHI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NTHI","date":"2026-09-29","current":-1.594006,"percent":0.97619,"low":-26.074295,"twenty":-4.098722,"median":-3.010317,"eighty":-2.187636,"high":-1.357276,"avg":-3.885305,"sd":3.201204,"marketCap":78547557},"quantilePoints":[{"date":"2024-03-28","current":-18.899455,"twenty":-18.899455,"median":-18.899455,"eighty":-18.899455,"marketCap":282000000},{"date":"2025-03-28","current":-18.905834,"twenty":-19.009816,"median":-18.905834,"eighty":-18.902007,"marketCap":224950380},{"date":"2025-04-04","current":-15.093157,"twenty":-20.260752,"median":-18.902645,"eighty":-16.151884,"marketCap":179585386},{"date":"2025-04-11","current":-14.179375,"twenty":-19.504518,"median":-17.739974,"eighty":-15.124667,"marketCap":168712785},{"date":"2025-04-17","current":-11.028403,"twenty":-19.044476,"median":-15.392499,"eighty":-12.855967,"marketCap":131221055},{"date":"2025-04-25","current":-9.437162,"twenty":-18.904558,"median":-14.667776,"eighty":-10.965384,"marketCap":112287731},{"date":"2025-05-02","current":-8.444606,"twenty":-18.667559,"median":-12.525115,"eighty":-9.437162,"marketCap":100477836},{"date":"2025-05-09","current":-10.398208,"twenty":-17.342951,"median":-11.028403,"eighty":-9.33318,"marketCap":123722709},{"date":"2025-05-16","current":-2.933338,"twenty":-15.682389,"median":-10.398208,"eighty":-8.444606,"marketCap":137753858},{"date":"2025-05-23","current":-2.969802,"twenty":-15.348385,"median":-9.44504,"eighty":-3.015179,"marketCap":139466268},{"date":"2025-05-30","current":-2.99006,"twenty":-15.171931,"median":-9.437162,"eighty":-2.969802,"marketCap":140417606},{"date":"2025-06-06","current":-3.034627,"twenty":-15.093157,"median":-9.311123,"eighty":-2.969802,"marketCap":142510552},{"date":"2025-06-13","current":-2.593006,"twenty":-14.242395,"median":-8.476116,"eighty":-2.937389,"marketCap":121771366},{"date":"2025-06-20","current":-1.928548,"twenty":-14.191979,"median":-7.853798,"eighty":-2.929004,"marketCap":90567453},{"date":"2025-06-27","current":-1.616577,"twenty":-12.855967,"median":-3.034627,"eighty":-2.802066,"marketCap":75916836},{"date":"2025-07-03","current":-2.362066,"twenty":-12.222621,"median":-3.010317,"eighty":-2.532985,"marketCap":110926104},{"date":"2025-07-11","current":-1.977167,"twenty":-11.425425,"median":-2.998163,"eighty":-2.362066,"marketCap":92850666},{"date":"2025-07-18","current":-1.786743,"twenty":-11.028403,"median":-2.99006,"eighty":-2.222692,"marketCap":83908082},{"date":"2025-07-25","current":-1.904238,"twenty":-10.981139,"median":-2.959854,"eighty":-1.949616,"marketCap":89425847},{"date":"2025-08-01","current":-1.98527,"twenty":-10.618776,"median":-2.937389,"eighty":-1.970684,"marketCap":93231202},{"date":"2025-08-08","current":-1.944754,"twenty":-10.133526,"median":-2.931642,"eighty":-1.939892,"marketCap":91328524},{"date":"2025-08-15","current":-2.102765,"twenty":-9.654579,"median":-2.909028,"eighty":-1.943134,"marketCap":98748967},{"date":"2025-08-22","current":-2.604584,"twenty":-9.443464,"median":-2.799635,"eighty":-1.954478,"marketCap":110548110},{"date":"2025-08-29","current":-3.15078,"twenty":-9.437162,"median":-2.795584,"eighty":-1.970684,"marketCap":133730643},{"date":"2025-09-05","current":-3.371966,"twenty":-9.437162,"median":-2.876616,"eighty":-1.980408,"marketCap":143118611},{"date":"2025-09-12","current":-4.405675,"twenty":-9.43086,"median":-2.918386,"eighty":-1.98527,"marketCap":186992991},{"date":"2025-09-19","current":-5.457439,"twenty":-9.377293,"median":-2.933338,"eighty":-1.993373,"marketCap":231633736},{"date":"2025-09-26","current":-4.681029,"twenty":-9.292217,"median":-2.939656,"eighty":-2.005528,"marketCap":198680053},{"date":"2025-10-03","current":-5.141458,"twenty":-8.961365,"median":-2.969802,"eighty":-2.008769,"marketCap":218222354},{"date":"2025-10-10","current":-5.407785,"twenty":-8.482417,"median":-2.99006,"eighty":-2.016872,"marketCap":229526233},{"date":"2025-10-17","current":-4.730683,"twenty":-8.444606,"median":-3.002214,"eighty":-2.039561,"marketCap":200787556},{"date":"2025-10-24","current":-3.769199,"twenty":-7.97196,"median":-3.022472,"eighty":-2.067922,"marketCap":159978635},{"date":"2025-10-31","current":-4.590749,"twenty":-7.105442,"median":-3.15078,"eighty":-2.071973,"marketCap":194848230},{"date":"2025-11-07","current":-4.446301,"twenty":-6.304447,"median":-3.298614,"eighty":-2.085748,"marketCap":188717312},{"date":"2025-11-14","current":-4.053582,"twenty":-5.457439,"median":-3.638293,"eighty":-2.120592,"marketCap":172048879},{"date":"2025-11-21","current":-2.32457,"twenty":-5.457439,"median":-3.482559,"eighty":-2.150574,"marketCap":113613569},{"date":"2025-11-28","current":-3.566132,"twenty":-5.449314,"median":-3.447134,"eighty":-2.162729,"marketCap":174295011},{"date":"2025-12-05","current":-3.725512,"twenty":-5.41591,"median":-3.522302,"eighty":-2.193521,"marketCap":182084733},{"date":"2025-12-12","current":-3.733481,"twenty":-5.411396,"median":-3.568124,"eighty":-2.214589,"marketCap":182474219},{"date":"2025-12-19","current":-2.797122,"twenty":-5.405979,"median":-3.570116,"eighty":-2.278603,"marketCap":136709607},{"date":"2025-12-26","current":-3.327062,"twenty":-5.398757,"median":-3.566132,"eighty":-2.301292,"marketCap":162610430},{"date":"2026-01-02","current":-3.295186,"twenty":-5.391535,"median":-3.474488,"eighty":-2.319914,"marketCap":161052485},{"date":"2026-01-09","current":-3.916768,"twenty":-5.368062,"median":-3.548202,"eighty":-2.33285,"marketCap":191432398},{"date":"2026-01-16","current":-3.466519,"twenty":-5.344589,"median":-3.566132,"eighty":-2.344813,"marketCap":169426436},{"date":"2026-01-23","current":-3.486442,"twenty":-5.296741,"median":-3.53824,"eighty":-2.348861,"marketCap":170400151},{"date":"2026-01-30","current":-3.486442,"twenty":-5.229933,"median":-3.552186,"eighty":-2.357204,"marketCap":170400151},{"date":"2026-02-06","current":-3.681683,"twenty":-5.174862,"median":-3.566132,"eighty":-2.362066,"marketCap":179942559},{"date":"2026-02-13","current":-4.169784,"twenty":-5.146875,"median":-3.570116,"eighty":-2.389761,"marketCap":203798580},{"date":"2026-02-20","current":-3.426674,"twenty":-5.12611,"median":-3.574101,"eighty":-2.410019,"marketCap":167479005},{"date":"2026-02-27","current":-4.020365,"twenty":-5.049824,"median":-3.613946,"eighty":-2.417236,"marketCap":196495717},{"date":"2026-03-06","current":-3.835101,"twenty":-4.966315,"median":-3.638073,"eighty":-2.428412,"marketCap":187440892},{"date":"2026-03-13","current":-3.660224,"twenty":-4.933814,"median":-3.653791,"eighty":-2.438178,"marketCap":178893747},{"date":"2026-03-20","current":-3.253532,"twenty":-4.851659,"median":-3.642057,"eighty":-2.502974,"marketCap":159016664},{"date":"2026-03-27","current":-2.981402,"twenty":-4.767698,"median":-3.621915,"eighty":-2.597637,"marketCap":145716276},{"date":"2026-04-02","current":-1.961459,"twenty":-4.735197,"median":-3.603287,"eighty":-2.595322,"marketCap":121897269},{"date":"2026-04-10","current":-1.961307,"twenty":-4.734294,"median":-3.574101,"eighty":-2.414974,"marketCap":121887825},{"date":"2026-04-17","current":-2.012281,"twenty":-4.720752,"median":-3.566132,"eighty":-2.352342,"marketCap":125055639},{"date":"2026-04-24","current":-1.920085,"twenty":-4.679223,"median":-3.562148,"eighty":-2.305948,"marketCap":119325998},{"date":"2026-05-01","current":-1.771769,"twenty":-4.657556,"median":-3.53824,"eighty":-2.205893,"marketCap":110108750},{"date":"2026-05-08","current":-2.630543,"twenty":-4.597971,"median":-3.502161,"eighty":-2.162729,"marketCap":163478290},{"date":"2026-05-15","current":-2.213061,"twenty":-4.588041,"median":-3.478473,"eighty":-2.19289,"marketCap":137533354},{"date":"2026-05-22","current":-3.511755,"twenty":-4.577207,"median":-3.486442,"eighty":-2.19724,"marketCap":135694649},{"date":"2026-05-29","current":-3.138303,"twenty":-4.577207,"median":-3.483777,"eighty":-2.19881,"marketCap":121264435},{"date":"2026-06-05","current":-2.990888,"twenty":-4.568179,"median":-3.474488,"eighty":-2.200003,"marketCap":115568297},{"date":"2026-06-12","current":-2.948302,"twenty":-4.559151,"median":-3.434643,"eighty":-2.209008,"marketCap":113922747},{"date":"2026-06-18","current":-3.151407,"twenty":-4.512205,"median":-3.406752,"eighty":-2.21225,"marketCap":121770758},{"date":"2026-06-26","current":-2.954853,"twenty":-4.486024,"median":-3.393823,"eighty":-2.226031,"marketCap":114175908},{"date":"2026-07-02","current":-2.922095,"twenty":-4.474288,"median":-3.367616,"eighty":-2.229383,"marketCap":112910100},{"date":"2026-07-10","current":-3.013469,"twenty":-4.460746,"median":-3.339093,"eighty":-2.231778,"marketCap":116440808},{"date":"2026-07-17","current":-2.181241,"twenty":-4.449912,"median":-3.327062,"eighty":-2.231778,"marketCap":84283436},{"date":"2026-07-24","current":-2.436279,"twenty":-4.432759,"median":-3.283232,"eighty":-2.231778,"marketCap":94138114},{"date":"2026-07-31","current":-2.342317,"twenty":-4.416509,"median":-3.25181,"eighty":-2.244708,"marketCap":90507443},{"date":"2026-08-07","current":-2.349029,"twenty":-4.389966,"median":-3.211511,"eighty":-2.26624,"marketCap":90766777},{"date":"2026-08-14","current":-1.763689,"twenty":-4.333179,"median":-3.181853,"eighty":-2.231004,"marketCap":83246101},{"date":"2026-08-21","current":-2.401422,"twenty":-4.279913,"median":-3.15078,"eighty":-2.244708,"marketCap":113347108},{"date":"2026-08-28","current":-2.42512,"twenty":-4.273416,"median":-3.115982,"eighty":-2.26624,"marketCap":114465665},{"date":"2026-09-04","current":-2.522546,"twenty":-4.230747,"median":-3.083785,"eighty":-2.27546,"marketCap":119064177},{"date":"2026-09-11","current":-1.927457,"twenty":-4.158229,"median":-3.040027,"eighty":-2.239017,"marketCap":90975968},{"date":"2026-09-18","current":-1.7958,"twenty":-4.109352,"median":-3.024048,"eighty":-2.209819,"marketCap":84761763},{"date":"2026-09-25","current":-1.737871,"twenty":-4.098722,"median":-3.013469,"eighty":-2.195101,"marketCap":82027512},{"date":"2026-09-29","current":-1.664143,"twenty":-4.098722,"median":-3.010317,"eighty":-2.187636,"marketCap":78547557}],"updateTime":1790840179529},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTHI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666536898","title":"Neonc Technologies - to Request Type B FDA Meeting for Neo100 Registrational Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666536898?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:35","pubTimestamp":1788960944,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN4510L8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666053639","title":"NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2666053639","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666053639?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:35","pubTimestamp":1788960900,"startTime":"0","endTime":"0","summary":"DENVER, Sept.  09, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ:NTHI) is entering a potentially important new phase with fresh institutional capital, encouraging","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358801/0/en/neonc-raises-15-million-at-market-adding-fuel-to-the-strong-neo100-data.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538657","title":"NeOnc Technologies Issues Warrants for 3,571,430 Shares in USD 15 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538657","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538657?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:03","pubTimestamp":1788955436,"startTime":"0","endTime":"0","summary":"NeOnc Technologies issues warrants for 3,571,430 shares in USD 15 million registered direct offeringNeOnc priced a USD 15 million registered direct offering with 3571430 common shares or pre-funded wa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL9rhVyX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4585","SG9999014039.USD","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","LU2095319765.USD","NDAQ","BK4007","NTHI","IE00BQXX3C00.GBP","BCDF","LU2210150020.SGD","BK4112","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU0314104364.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666853881","title":"Neonc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules with New and Existing Institutional Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666853881","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666853881?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA2GZP7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538688","title":"Neonc Technologies - to Sell 3,571,430 Shares and Warrants at $4.20 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538688","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538688?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA2GZP7Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666385955","title":"Press Release: NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules with New and Existing Institutional Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666385955","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666385955?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"CALABASAS, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (\"NeOnc\" or the \"Company\"), a multi-Phase 2 clinical-stage biopharmaceutical company developing n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JEPQ","QQQM","TQQQ","BK4022","TECS","03160","BK4585","MNQmain",".IXIC","PSQ","QYLG","SQQQ","QQQE","QQQJ","TQQY","NDX","BK4604","CNS","R","GPIQ","QID","ISBC","QLD","BK4211","BK4588","03086","IYW","BK4555","BK4007","BK4232","QQQA","QDTE","IND","NVIW.SI","ONEQ","QQQY","NQmain","QQQ","FTEC","TM","NTHI","BK4135","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373039","title":"NeOnc' Phase 2 Data Could Put Cancer on the Ropes","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373039","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373039?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:39","pubTimestamp":1788871140,"startTime":"0","endTime":"0","summary":"NeOnc Looking to Turn Phase 2 Win into FDA ActionDENVER, Sept.  08, 2026  --  – ForNeOnc Technologies Holdings , the Phase 2a question has been answered. Now comes the question that could matter even more to the market: What will the FDA do with the data?toward the much more consequential question of how regulators might want that signal developed. The broader pipeline gives investors another reason to watch. In June, NeOnc received UAE IND authorization for NEO100 covering three adult programs ranging from Phase 1 through Phase 2, as well as pediatric development. NEO212, the company's oral perillyl alcohol-temozolomide conjugate, also received UAE IND clearance after completing Phase 1 dose escalation and establishing a recommended Phase 2 dose of 610 mg. There is also an unusual insider-activity angle. SEC-filed information shows director Thomas Chen purchased 33,787 shares at a weighted average $3.8477 on August 14 and another 2,472 shares at $4.0445 on August 17. Additional purcha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357672/0/en/neonc-phase-2-data-could-put-cancer-on-the-ropes.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322812","title":"NeOnc Technologies Price Target Maintained with a $15.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322812","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322812?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:57","pubTimestamp":1788865020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NTHI/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662366091","title":"NeOnc’s Phase 2A Success Could Set the Stage for Something Much Bigger","url":"https://stock-news.laohu8.com/highlight/detail?id=2662366091","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662366091?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:07","pubTimestamp":1787926020,"startTime":"0","endTime":"0","summary":"to “What would it take to get NEO100 to a potential approval?”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/28/3352739/0/en/neonc-s-phase-2a-success-could-set-the-stage-for-something-much-bigger.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662175127","title":"NeOnc’s Clinical Story Is Now the Main Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2662175127","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662175127?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:39","pubTimestamp":1787751540,"startTime":"0","endTime":"0","summary":"DENVER, Aug.  26, 2026  -- NeOnc Technologies Holdings  has reached a point where the market conversation can move toward a much more consequential question: What happens if NEO100’s clinical results translate into a viable regulatory pathway for a difficult-to-treat form of brain cancer?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351481/0/en/neonc-s-clinical-story-is-now-the-main-event.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4007","BK4588","NTHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661929902","title":"NeOnc Technologies Amends 8-K to Name Nasim Shomali to Audit Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2661929902","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661929902?lang=en_us&edition=fundamental","pubTime":"2026-08-22 02:59","pubTimestamp":1787338770,"startTime":"0","endTime":"0","summary":"NeOnc Technologies amends 8-K to name Nasim Shomali to audit committeeNeOnc Technologies filed an amended 8-K to update board committee assignments omitted from its July 2, 2026 report.Nasim Shomali w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4NLHMr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661261695","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2661261695","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661261695?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:00","pubTimestamp":1787306400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·PicS N.V. Class A                               2Q       .40       AMC. ·Bank Nova Scot.                                  3Q      1.49   6:00 AM. ·Everpure Inc A                                     2Q       .58   4:05 PM. ·JM Smucker Co.                                   1Q      2.22   7:00 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDLR","MZTI","MRVL","AFRM","HEI.A","BBAR","NCNO","BZ","DG","BBW","GAP","NSSC","MBUU","CRM","VIPS","CSIQ","HRL","DCI","DLTR","LI","NTHI","HPQ","CM","BOX","NTNX","JKS","BNS","INTU","JOYY","MCFT","KSS","BBY","BJ","CRWD","DY","ADSK","AVNW","BEKE","ESTC","A","BBWI","DKS","IREN","LTRX","BILI","HEI","BMO","BURL","CMBT","HQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661255174","title":"Neonc Technologies CEO Thomas C. Chen Acquires $70,010 of Common Shares Via IRA","url":"https://stock-news.laohu8.com/highlight/detail?id=2661255174","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661255174?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:16","pubTimestamp":1787274992,"startTime":"0","endTime":"0","summary":"Neonc Technologies CEO Thomas C. Chen acquires $70,010 of common shares via IRANeonc Technologies CEO Thomas C. Chen reported an indirect purchase of 12,757 common shares at a weighted average price o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL7CMxLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Neonc Technologies CEO Thomas C. Chen Acquires $70,010 of Common Shares Via IRA","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660100282","title":"NeOnc Technologies Hosts Annual Shareholder Meeting Via Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2660100282","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660100282?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:01","pubTimestamp":1787230877,"startTime":"0","endTime":"0","summary":"NeOnc Technologies hosts annual shareholder meeting via webcastNeOnc Technologies Holdings held its annual shareholder meeting on Aug. 14, 2026.Shareholders elected Victoria Medvec and Steven Giannott","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL2H01Kq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660411424","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2660411424","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660411424?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:00","pubTimestamp":1787133600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·Estee Lauder Co.                                  4Q       .32   6:00 AM. ·FLEX LNG Ltd                                    2Q       .62   1:00 AM. ·Adv Auto Parts                                   2Q       .81   6:30 AM. ·Atour Life ADR                                  2Q       .58   6:00 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMTC","ATAT","DE","BILL","FLNG","FLUX","BOX","HEI","NTES","DOMO","NCNO","OSIS","CDLR","BMA","EL","VIPS","PDD","NMM","BEKE","NTHI","ALVO","SCSC","ATHM","HEI.A","FUTU","PICS","PRLD","LOW","ANF","MZTI","BEEM","COTY","MRKR","NDSN","BNS","BZ","FLO","KC","GGAL","INTU","BMO","LYTS","BJ","BABA","AAP","ROST","DKS","JOYY","ADI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660149394","title":"NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t","url":"https://stock-news.laohu8.com/highlight/detail?id=2660149394","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660149394?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:18","pubTimestamp":1787062680,"startTime":"0","endTime":"0","summary":"NeOnc Insider Open Market Buying may be the Signal Worth WatchingDENVER, Aug.  18, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) --NeOnc Technologies Holdings (NASDAQ: NTHI) has just added another pote","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/18/3347038/0/en/neonc-technologies-talk-is-cheap-insider-buying-isn-t.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660343053","title":"Neonc Technologies CEO Amir F Heshmatpour Acquires USD 58,521 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660343053","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660343053?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:50","pubTimestamp":1787007027,"startTime":"0","endTime":"0","summary":"Neonc Technologies CEO Amir F Heshmatpour acquires USD 58,521 of common sharesNeonc Technologies: CEO, President Amir F. Heshmatpour disclosed open-market purchases totaling 15,000 common shares.Direc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL268MWD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Neonc Technologies CEO Amir F Heshmatpour Acquires USD 58,521 of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NTHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660589438","title":"NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660589438","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660589438?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:45","pubTimestamp":1786970700,"startTime":"0","endTime":"0","summary":"Every meaningful milestone can reduce some of that uncertainty, which is why successful Phase 2a data can be transformative for a biotech company even before the drug generates commercial revenue. In NTHI’s case, the reported 48.9% six-month PFS result substantially exceeded the company's 20% historical benchmark, while the company also reported median overall survival of approximately 26 months and no major toxicities. The next question is no longer simply whether NEO100 can produce a clinical signal and becomes How far can NeOnc take that signal?That is where capital becomes critical. Clinical Success Creates a New Kind of Financing Opportunity A promising Phase 2a result can potentially change the economics of raising money because management is no longer asking investors to finance only a scientific hypothesis. The company can point to an actual human clinical outcome. That doesn't eliminate risk, establish regulatory approval or guarantee that a larger study will reproduce the res","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/17/3346121/0/en/nthi-s-nasdaq-advantage-takes-on-new-meaning-after-its-breakthrough-phase-2a-results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCLG","NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659989361","title":"NeOnc Technologies Releases Transcript of Investor Call on Neo100-01 Phase 2a Trial Results in Recurrent IDH1-Mutant High-Grade Glioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2659989361","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659989361?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:22","pubTimestamp":1786656134,"startTime":"0","endTime":"0","summary":"NeOnc Technologies releases transcript of investor call on NEO100-01 Phase 2a trial results in recurrent IDH1-mutant high-grade gliomaNeonc Technologies hosted an investor call on Aug. 12, 2026 to dis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL7HkSQ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164587","title":"The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164587","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164587?lang=en_us&edition=fundamental","pubTime":"2026-08-14 02:31","pubTimestamp":1786645860,"startTime":"0","endTime":"0","summary":"Stunning Brain-Cancer Data Are Putting NeOnc’s Nose-to-Brain Delivery Platform, and Its Broader Potential, Front and CenterDENVER, Aug.  13, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings’ (NASD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344837/0/en/the-nose-knows-why-neonc-s-patent-portfolio-could-make-nthi-more-than-a-one-drug-biotech.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4588","NTHI","BK4585","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":118,"code":"91000000","status":"200"}]}}